Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Wiese

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
European Journal of Medicinal Chemistry|August 26, 2017
Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2)Michael K Krapf, Jennifer Gallus, Michael Wiese
Biochimica Et Biophysica Acta. Biomembranes|November 5, 2016
Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1)Sven Marcel Schmitt, Katja Stefan, Michael Wiese
Journal of Medicinal Chemistry|March 5, 2016
Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1)Sven Marcel Schmitt, Katja Stefan, Michael Wiese
Molecular Informatics|July 29, 2016
A Microarray Tool Provides Pathway and GO Term AnalysisMartin Koch, Hans-Dieter Royer, Michael Wiese
Chemmedchem|January 5, 2008
Identification of putative binding sites of P-glycoprotein based on its homology modelChristoph Globisch, Ilza K Pajeva, Michael Wiese
Bioorganic & Medicinal Chemistry|November 25, 2011
Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance proteinKapil Juvale, Veronika F S Pape, Michael Wiese
Chemmedchem|March 5, 2015
Scaffold identification of a new class of potent and selective BCRP inhibitorsFederico Marighetti, Kerstin Steggemann, Maria Karbaum, et al.
Chemmedchem|November 15, 2012
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitorsFederico Marighetti, Kerstin Steggemann, Markus Hanl, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
Are low molecular weight heparins able to sensitize chemoresistant tumor cells?Daniel P Stölting, Ulrich Jaehde, Michael Wiese, et al.
Journal of Medicinal Chemistry|August 5, 2018
2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2Michael K Krapf, Jennifer Gallus, Vigneshwaran Namasivayam, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
European Journal of Medicinal Chemistry|August 26, 2017
Synthesis and biological investigation of 2,4-substituted quinazolines as highly potent inhibitors of breast cancer resistance protein (ABCG2)Michael K Krapf, Jennifer Gallus, Michael Wiese
Biochimica Et Biophysica Acta. Biomembranes|November 5, 2016
Pyrrolopyrimidine derivatives and purine analogs as novel activators of Multidrug Resistance-associated Protein 1 (MRP1, ABCC1)Sven Marcel Schmitt, Katja Stefan, Michael Wiese
Journal of Medicinal Chemistry|March 5, 2016
Pyrrolopyrimidine Derivatives as Novel Inhibitors of Multidrug Resistance-Associated Protein 1 (MRP1, ABCC1)Sven Marcel Schmitt, Katja Stefan, Michael Wiese
Molecular Informatics|July 29, 2016
A Microarray Tool Provides Pathway and GO Term AnalysisMartin Koch, Hans-Dieter Royer, Michael Wiese
Chemmedchem|January 5, 2008
Identification of putative binding sites of P-glycoprotein based on its homology modelChristoph Globisch, Ilza K Pajeva, Michael Wiese
Bioorganic & Medicinal Chemistry|November 25, 2011
Investigation of chalcones and benzochalcones as inhibitors of breast cancer resistance proteinKapil Juvale, Veronika F S Pape, Michael Wiese
Chemmedchem|March 5, 2015
Scaffold identification of a new class of potent and selective BCRP inhibitorsFederico Marighetti, Kerstin Steggemann, Maria Karbaum, et al.
Chemmedchem|November 15, 2012
Synthesis and quantitative structure-activity relationships of selective BCRP inhibitorsFederico Marighetti, Kerstin Steggemann, Markus Hanl, et al.
International Journal of Clinical Pharmacology and Therapeutics|December 25, 2012
Are low molecular weight heparins able to sensitize chemoresistant tumor cells?Daniel P Stölting, Ulrich Jaehde, Michael Wiese, et al.
Journal of Medicinal Chemistry|August 5, 2018
2,4,6-Substituted Quinazolines with Extraordinary Inhibitory Potency toward ABCG2Michael K Krapf, Jennifer Gallus, Vigneshwaran Namasivayam, et al.
Pageof 12